Overview: Cause and prevention in biowarfare and bioterrorism

Vaccine

Volumn 20, Issue 25-26, 2002, Pages 3055-3067

  Hilleman, Maurice R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Biological weapons; Bioterrorism; Disease prevention; Disease treatment

Indexed keywords

ANTIBIOTIC AGENT; VACCINE; ANTIINFECTIVE AGENT; IMMUNOLOGICAL ADJUVANT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BIOLOGICAL WARFARE; DRUG RESEARCH; FEASIBILITY STUDY; HEALTH; HUMAN; HUNGER; IMMUNITY; IMMUNIZATION; INTERNATIONAL COOPERATION; POVERTY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VIRUS INFECTION; ANIMAL; CIVIL DEFENSE; CROP; ENVIRONMENTAL MONITORING; FORECASTING; FORENSIC MEDICINE; HAZARDOUS WASTE; HEALTH CARE PLANNING; INNATE IMMUNITY; INSTRUMENTATION; METHODOLOGY; SOCIAL PROBLEM;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; ANTI-INFECTIVE AGENTS; BIOLOGICAL WARFARE; BIOTERRORISM; CIVIL DEFENSE; CONTAINMENT OF BIOHAZARDS; CROPS, AGRICULTURAL; ENVIRONMENTAL MONITORING; FORECASTING; FORENSIC MEDICINE; HEALTH PRIORITIES; HUMAN; IMMUNITY, NATURAL; INTERNATIONAL COOPERATION; SOCIAL PROBLEMS; VACCINES; WORLD HEALTH; ANIMALS; ANTI-BACTERIAL AGENTS; HUMANS;

EID: 0037135667     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00300-6     Document Type: Review

References (102)

1. Biological warfare: A historical perspective
2. Biological weapons in the 20th century: A review and analysis
3. Report to the Secretary of War: Biological warfare
4. Verifying compliance to the Biological and Toxin Weapons Convention
5. USA goes it alone again on bioweapons convention
6. Nuclear blindness: An overview of the biological weapons programs of the former Soviet Union and Iraq
7. Biological weapons control: Prospects and implications for the future
8. Iraq's biological warfare agents: A comprehensive analysis
9. Iraq's biological weapons: The past as future?
10. Biological warfare threats in perspective
11. Bioweapons treaty in disarray as US blocks plans for verification
12. Weapons inspections challenge: Pharma industry
13. Strengthening the Biological Weapons Conventions
14. The bioweapons convention's impact on bioindustry
15. US officials clash with industry executives over BWC
16. Universities and the Biological and Toxin Weapons Convention: What burdens will proposal for compliance declarations pose?
17. The Biological Weapons Convention and the pharmaceutical industry: The views of the United Kingdom
18. Putting teeth in the Biological Weapons Convention
19. Addressing bioterrorist threats: Where do we go from here?
20. The prospect of domestic bioterrorism
21. Mechanisms of antimicrobial resistance: Their clinical relevance in the new millennium
22. Impact of molecular biology on antibiotic susceptibility: Testing and therapy
23. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox
24. The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox
25. Antibodies for defense against biological attack
26. 'Borrowed immunity' may save future victims
27. Many viruses are potential agents of bioterrorism
28. Potential biological weapons threats
29. Bioterrorism: Relevance to allergy and immunology in clinical practice
30. Bioterrorism: A clear and present danger
31. Anthrax as a biological weapon: Medical and public health management
32. Anthrax vaccine begins a new round of tests
33. War against anthrax
34. Smallpox as a biological weapon: Medical and public health management
35. Smallpox: Clinical and epidemiological features
36. Clinical responses to undiluted and diluted smallpox vaccine
37. Smallpox vaccination policy: The need for dialogue
38. The case for voluntary smallpox vaccination
39. Report summary: Public health assessment of potential biological terrorism agents
40. Clinical recognition and management of patients exposed to biological warfare agents
41. Plague as a biological weapon
42. Vaccination against bubonic and pneumonic plague
43. Tularemia as a biological weapon: Medical and public health management
44. Hemorrhagic fever viruses as biological weapons
45. Recent advances in vaccines against viral haemorrhagic fevers
46. Evaluation in non-human primates of vaccines against Ebola virus
47. Development of a preventive vaccine for Ebola virus infection in primates
48. Botulinum toxin as a biological weapon: Medical and public health management
49. Botulinum surveillance and emergency response: A public health strategy for a global challenge
50. A review of emergency foot-and-mouth disease (FMD) vaccines
51. Bioterrorism
52. Past, present, and future of antimicrobial agents
53. Antibacterial and antifungal drug discovery
54. The new antibiotics: Can novel antibacterial treatments combat the rising tide of drug-resistant infections?
55. Genomics and innovation in antibiotics
56. Molecular targets for antiviral agents
57. Beyond chicken soup
58. The green revolution: Plants as heterologous expression vectors
59. Plant-based vaccines: Unique advantages
60. Edible vaccines: Not quite ready for prime time
61. Biological warfare against crops
62. Editorial on bioterrorism and biowarfare: What to do
63. The war against disease: Investing in health, investing in our common future
64. Interview with Sachs JD. An economist's view of health
65. GAVI, the first steps: Lessons for the Global Fund
66. Gates Foundation rearranges public health universe
67. The global alliance for vaccines and immunization: A millennial challenge
68. World poverty and hunger: The challenge for science
69. Rice boiled down to bare essentials
70. The rice squad
71. Africa looks to new breed of rice to combat food shortages
72. The 1979 anthrax epidemic in the USSR: Applied science and political controversy
73. Antibiotics that resist resistance
74. Virtually assured detection and response: Utilizing science, technology and policy against bioterrorism
75. Tackling grand challenges with powerful technologies
76. Robotic laboratory automation
77. PCR detection of bacteria in 7 min
78. New test could speed bioweapon detection
79. Rapid-cycle, real-time PCR: A revolution for clinical microbiology
80. Bioterrorism: Biotechnology to the rescue
81. Molecular testing for infectious disease
82. The science of detecting terror
83. The Sverdlosk anthrax outbreak of 1979
84. Innate immunity in the Aegean ancient pathways for today's survival
85. Overview of vaccinology with special reference to papillomavirus vaccines